Johnson & Johnson (JNJ) CEO: We Have No Plans To Leave The U.S.  
7/18/2014 8:10:34 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Johnson & Johnson’s strong second-quarter earnings are thanks to the company’s focus on long-term goals, particularly in the pharmaceutical business, said CEO Alex Gorsky.

Gorsky joined FBN’s Maria Bartiromo Thursday to discuss the company’s earnings and future plans. Johnson & Johnson (JNJ) sales grew by 9.1% in the second quarter to $19.5 billion, beating expectations of $18.99 billion.

Help employers find you! Check out all the jobs and post your resume.